Orum Therapeutics Holds Extraordinary Shareholders Meeting

• Orum Therapeutics shareholders approved amendments to the articles of incorporation at an extraordinary general meeting on Oct. 23, 2026.
• Shareholders approved appointments of Geoffrey Harris Meyerson as non-executive director and Peter Unnam Park as independent director.
• Separate resolutions to grant stock options and approve stock option grants also passed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orum Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023900837), on October 23, 2026, and is solely responsible for the information contained therein.